Faculty Opinions recommendation of HIV treatment response and prognosis in Europe and North America in the first decade of highly active antiretroviral therapy: a collaborative analysis.

Author(s):  
Anthony Harries
2011 ◽  
Vol 1 (1) ◽  
pp. 5 ◽  
Author(s):  
Rajakrishnan Vijayakrishnan ◽  
Sourbha Dani ◽  
Aparna Ramasubramanian ◽  
Rekha Nair ◽  
Tony M. Samaha

HIV-associated thrombocytopenia is a dis- ease which can be recurrent to standard therapy which includes highly active antiretroviral therapy (HAART) therapy, steroids and immunoglobulin. We report a patient with HIV and hepatitis C who presented with resistant thrombocytopenia. Treatment with Eltrombopag – a thrombopoeitin receptor agonist showed initial good response with recurrence of thrombocytopenia. This novel agent could be considered as a treatment option prior to splenectomy and may be useful as a tempo- rizing measure.


2005 ◽  
Vol 175 (3) ◽  
pp. 2010-2017 ◽  
Author(s):  
Erwan Piriou ◽  
Christine A. Jansen ◽  
Karel van Dort ◽  
Iris De Cuyper ◽  
Nening M. Nanlohy ◽  
...  

The Lancet ◽  
2002 ◽  
Vol 360 (9327) ◽  
pp. 119-129 ◽  
Author(s):  
Matthias Egger ◽  
Margaret May ◽  
Geneviève Chêne ◽  
Andrew N Phillips ◽  
Bruno Ledergerber ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document